Arnqvist HJ - Search Results

1

Unchanged incidence of severe retinopathy in a population of Type 1 diabetic patients with marked reduction of nephropathy.

Bojestig M, Arnqvist HJ, Karlberg BE, Ludvigsson J. Bojestig M, et al. Among authors: arnqvist hj. Diabet Med. 1998 Oct;15(10):863-9. doi: 10.1002/(SICI)1096-9136(199810)15:10<863::AID-DIA665>3.0.CO;2-O. Diabet Med. 1998. PMID: 9796888

2

The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998.

Pundziute-Lyckå A, Dahlquist G, Nyström L, Arnqvist H, Björk E, Blohmé G, Bolinder J, Eriksson JW, Sundkvist G, Ostman J; Swedish Childhood Diabetes Study Group. Pundziute-Lyckå A, et al. Diabetologia. 2002 Jun;45(6):783-91. doi: 10.1007/s00125-002-0845-2. Epub 2002 May 8. Diabetologia. 2002. PMID: 12107721

3

[Standards for long-term measures of blood sugar are established].

Arnqvist H, Wallensteen M, Jeppson JO. Arnqvist H, et al. Lakartidningen. 1997 Dec 10;94(50):4789-90. Lakartidningen. 1997. PMID: 9445960 Swedish. No abstract available.

4

Influence of metabolic control on the blood-retinal barrier in streptozocin diabetic rats.

Kernell A, Dahlkvist H, Arnqvist H, Ludvigsson J. Kernell A, et al. Graefes Arch Clin Exp Ophthalmol. 1985;222(4-5):179-81. doi: 10.1007/BF02133669. Graefes Arch Clin Exp Ophthalmol. 1985. PMID: 15835015

5

No pharmacokinetic effect of retaining the infusion site up to four days during continuous subcutaneous insulin infusion therapy.

Olsson PO, Arnqvist H, Asplund J. Olsson PO, et al. Diabet Med. 1993 Jun;10(5):477-80. doi: 10.1111/j.1464-5491.1993.tb00102.x. Diabet Med. 1993. PMID: 8334830

6

Pre- and postprandial hyperinsulinemia during insulin pump treatment; role of the subcutaneous bolus and basal infusion.

Olsson PO, Jorfeldt L, Arnqvist H, Gerhardsson P. Olsson PO, et al. Diabetes Res. 1991 Feb;16(2):55-61. Diabetes Res. 1991. PMID: 1817806

7

Overnight metabolic control with bedtime injection of intermediate-acting insulin or continuous subcutaneous insulin infusion.

Olsson PO, Arnqvist H, Von Schenck H, Ottosson AM. Olsson PO, et al. Diabetes Care. 1987 Nov-Dec;10(6):702-6. doi: 10.2337/diacare.10.6.702. Diabetes Care. 1987. PMID: 3322726

8

Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults: a prospective follow-up of the nationwide Diabetes Incidence Study in Sweden.

Schölin A, Björklund L, Borg H, Arnqvist H, Björk E, Blohmé G, Bolinder J, Eriksson JW, Gudbjörnsdottir S, Nyström L, Ostman J, Karlsson AF, Sundkvist G; Diabetes Incidence Study in Sweden. Schölin A, et al. J Intern Med. 2004 Mar;255(3):384-91. doi: 10.1046/j.1365-2796.2003.01273.x. J Intern Med. 2004. PMID: 14871463

9

Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus--a nationwide study.

Ostman J, Landin-Olsson M, Törn C, Palmer J, Lernmark A, Arnqvist H, Björk E, Bolinder J, Blohmé G, Eriksson J, Littorin B, Nyström L, Scherstén B, Sundkvist G, Wibell L. Ostman J, et al. Diabet Med. 2000 Apr;17(4):269-74. doi: 10.1046/j.1464-5491.2000.00265.x. Diabet Med. 2000. PMID: 10821292

10

Autoimmune (type 1) diabetes in young adults in Sweden.

Ostman J, Lernmark A, Landin-Olsson M, Sundkvist G, Palmer J, Arnqvist H, Blohmé G, Lithner F, Littorin B, Nyström L, Scherstén B, Wibell L. Ostman J, et al. Horm Metab Res. 1996 Jul;28(7):348-50. doi: 10.1055/s-2007-979812. Horm Metab Res. 1996. PMID: 8858383 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results